<?xml version="1.0" encoding="UTF-8"?><CAS version="2"><uima.cas.Sofa _indexed="0" _id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="P10717612A0000 BACKGROUND: The aim of this study was to determine the response rates and toxicity of two regimens containing granulocyte-macrophage-colony stimulating factor (GM-CSF) in combination with interleukin-2 (IL-2) in the treatment of patients with metastatic renal cell carcinoma."/><uima.tcas.DocumentAnnotation _indexed="1" _id="8" _ref_sofa="1" begin="0" end="290" language="x-unspecified"/><edu.cmu.tanl.type.gene _indexed="1" _id="13" _ref_sofa="1" begin="92" end="137" Gene="granulocyte-macrophage-colony stimulating factor"/><edu.cmu.tanl.type.gene _indexed="1" _id="18" _ref_sofa="1" begin="139" end="144" Gene="GM-CSF"/><edu.cmu.tanl.type.gene _indexed="1" _id="23" _ref_sofa="1" begin="163" end="175" Gene="interleukin-2"/><edu.cmu.tanl.type.gene _indexed="1" _id="28" _ref_sofa="1" begin="177" end="180" Gene="IL-2"/></CAS>